Mechanistic Pathogenesis of Endothelial Dysfunction in Diabetic Nephropathy and Retinopathy

被引:78
|
作者
Yang, Jing [1 ,2 ,3 ,4 ]
Liu, Zhangsuo [2 ,3 ,4 ,5 ]
机构
[1] First Affiliated Hosp Zhengzhou Univ, Dept Ophthalmol, Zhengzhou, Peoples R China
[2] Zhengzhou Univ, Res Inst Nephrol, Zhengzhou, Peoples R China
[3] Henan Prov Res Ctr Kidney Dis, Zhengzhou, Peoples R China
[4] Key Lab Precis Diag & Treatment Chron Kidney Dis, Zhengzhou, Henan, Peoples R China
[5] First Affiliated Hosp Zhengzhou Univ, Dept Integrated Tradit & Western Nephrol, Zhengzhou, Peoples R China
来源
基金
中国国家自然科学基金;
关键词
diabetic retinopathy (DR); diabetic nephropathy (DN); diabetic endothelial dysfunction; CircRNAs; exosomes; cellular crosstalk; BLOOD-RETINAL BARRIER; INTERCELLULAR-ADHESION MOLECULE-1; GLOMERULAR-BASEMENT-MEMBRANE; GROWTH-FACTOR; EXTRACELLULAR VESICLES; OXIDATIVE STRESS; INFLAMMATORY CYTOKINES; TRANSCRIPTIONAL FACTOR; SIGNALING PATHWAYS; GLOBAL PREVALENCE;
D O I
10.3389/fendo.2022.816400
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetic nephropathy (DN) and diabetic retinopathy (DR) are microvascular complications of diabetes. Microvascular endothelial cells are thought to be the major targets of hyperglycemic injury. In diabetic microvasculature, the intracellular hyperglycemia causes damages to the vascular endothelium, via multiple pathophysiological process consist of inflammation, endothelial cell crosstalk with podocytes/pericytes and exosomes. In addition, DN and DR diseases development are involved in several critical regulators including the cell adhesion molecules (CAMs), the vascular endothelial growth factor (VEGF) family and the Notch signal. The present review attempts to gain a deeper understanding of the pathogenesis complexities underlying the endothelial dysfunction in diabetes diabetic and retinopathy, contributing to the development of new mechanistic therapeutic strategies against diabetes-induced microvascular endothelial dysfunction.
引用
收藏
页数:19
相关论文
共 50 条
  • [31] Role of Endothelial Dysfunction and Arterial Stiffness in the Development of Diabetic Retinopathy
    Siasos, Gerasimos
    Gouliopoulos, Nikolaos
    Moschos, Marilita M.
    Oikonomou, Evangelos
    Kollia, Christina
    Konsola, Theodosia
    Athanasiou, Dimitrios
    Siasou, Georgia
    Mourouzis, Konstantinos
    Zisimos, Konstantinos
    Papavassiliou, Athanasios G.
    Stefanadis, Christodoulos
    Tousoulis, Dimitris
    DIABETES CARE, 2015, 38 (01) : E9 - E10
  • [32] Pathogenesis of Diabetic Nephropathy
    Claudia van Dijk
    Tomas Berl
    Reviews in Endocrine and Metabolic Disorders, 2004, 5 : 237 - 248
  • [33] Pathogenesis of diabetic nephropathy
    Chowdhury, TA
    Barnett, AH
    Bain, SC
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 1996, 7 (09): : 320 - 323
  • [34] The pathogenesis of diabetic nephropathy
    Dronavalli, Suma
    Duka, Irena
    Bakris, George L.
    NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2008, 4 (08): : 444 - 452
  • [35] THE ROLE OF LIPID METABOLISM IN THE DEVELOPMENT OF ENDOTHELIAL DYSFUNCTION IN DIABETIC NEPHROPATHY
    Mammadzada, A. Y.
    Ismayilova, Sh. G.
    WORLD OF MEDICINE AND BIOLOGY, 2023, 83 (01): : 126 - 130
  • [36] Pathogenesis of diabetic nephropathy
    Cao, Zemin
    Cooper, Mark E.
    JOURNAL OF DIABETES INVESTIGATION, 2011, 2 (04) : 243 - 247
  • [37] Pathogenesis of diabetic nephropathy
    van Dijk, C
    Berl, T
    REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2004, 5 (03): : 237 - 248
  • [38] The pathogenesis of diabetic nephropathy
    Suma Dronavalli
    Irena Duka
    George L Bakris
    Nature Clinical Practice Endocrinology & Metabolism, 2008, 4 : 444 - 452
  • [39] Pathogenesis of diabetic nephropathy
    Ryuichi Kikkawa
    Masakazu Haneda
    Clinical and Experimental Nephrology, 1997, 1 (1) : 3 - 11
  • [40] Pathogenesis of diabetic nephropathy
    Raptis, AE
    Viberti, G
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2001, 109 : S424 - S437